⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15658012 | 0.78 | — | — | |
| SCHEMBL31409405 | 0.71 | — | — | |
| SCHEMBL31409432 | 0.71 | — | — | |
| SCHEMBL4257796 | 0.71 | — | — | |
| SCHEMBL14659147 | 0.69 | — | — | |
| SCHEMBL30685402 | 0.69 | — | — | |
| SCHEMBL16431979 | 0.69 | — | — | |
| SCHEMBL7154734 | 0.69 | — | — | |
| SCHEMBL489439 | 0.69 | — | — | |
| SCHEMBL5382389 | 0.68 | AKR1B1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1546150-B1 | PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES | AMURA THERAPEUTICS LTD (GB) | 2009-03-04 | — | — | EP | claimed |
| US-20060100431-A1 | Biologically active compounds | AMURA THERAPEUTICS LIMITED (GB) | 2006-05-11 | — | — | US | claimed |
| EP-1546150-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | Amura Therapeutics Limited (GB) | 2005-06-29 | — | — | EP | claimed |
| WO-2004007501-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2004-01-22 | — | — | WO | claimed |
| CN-103858269-B | Electrolyte solution for electrochemical devices | 和光纯药工业株式会社 | 2017-02-15 | — | — | CN | disclosed |
| US-9263767-B2 | Electrolyte solution for electrochemical devices | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2016-02-16 | — | — | US | disclosed |
| US-20140162143-A1 | ELECTROLYTE SOLUTION FOR ELECTROCHEMICAL DEVICES | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-06-12 | — | — | US | disclosed |
| CN-103858269-A | Electrolyte solution for electrochemical devices | WAKO PURE CHEM IND LTD | 2014-06-11 | — | — | CN | disclosed |
| EP-2738862-A1 | ELECTROLYTE SOLUTION FOR ELECTROCHEMICAL DEVICES | Wako Pure Chemical Industries, Ltd. (JP) | 2014-06-04 | — | — | EP | disclosed |
| US-8003913-B2 | Base plate with electrodes, process for producing the same, and electro-optical device | FUJIFILM CORPORATION (JP) | 2011-08-23 | — | — | US | disclosed |
| EP-1546150-B1 | PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES | AMURA THERAPEUTICS LTD (GB) | 2009-03-04 | — | — | EP | disclosed |
| WO-2007006714-A1 | CYSTEINE PROTEASE INHIBITORS | MEDIVIR AB (SE) | 2007-01-18 | — | — | WO | disclosed |
| US-20060262375-A1 | Base plate with electrodes, process for producing the same, and electro-optical device | FUJI PHOTO FILM CO., LTD. | 2006-11-23 | — | — | US | disclosed |
| US-20060100431-A1 | Biologically active compounds | AMURA THERAPEUTICS LIMITED (GB) | 2006-05-11 | — | — | US | disclosed |
| EP-1546150-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | Amura Therapeutics Limited (GB) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004007501-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2004-01-22 | — | — | WO | disclosed |
| WO-2004007501-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2004-01-22 | — | — | WO | disclosed |
| EP-0107366-A1 | Pyrrolidinone analogs and precursors | ELI LILLY AND COMPANY (US) | 1984-05-02 | — | — | EP | disclosed |